| Literature DB >> 35835412 |
Lingying Ye1, Wing Fai Li2, Jinsong Shao1, Zhengmei Xu3, Jintao Ju4, Huji Xu5.
Abstract
Entities:
Mesh:
Year: 2022 PMID: 35835412 PMCID: PMC9273521 DOI: 10.1016/j.jinf.2022.07.006
Source DB: PubMed Journal: J Infect ISSN: 0163-4453 Impact factor: 38.637
Figure AA. The cumulative incidence functions for the time it took for patient discharge. The 50% and 90% cumulative incidence of discharge were labeled in the graph (n=165,760). B. Average length of hospital stay for different age groups. Results were presented as violin plots. One-way ANOVA with Dunnett's multiple comparison tests were performed for any age group compared to the age group 20-29 (control), **** P<0.0001 (n=165,760). C. Average length of hospital stay for patients with or without chronic diseases. Results of patients with (+) or without (-) hypertension or diabetes were analyzed. Unpaired t-tests, **** P<0.0001 (Hypertension n=2,707, Diabetes n=1,096, Total n=37,825). D. Impact of patient source on the average length of hospital stays. Results of patients discovered at their local community or in the fever clinic were shown. Unpaired t-tests, **** P<0.0001 (Community n=24,479, Fever Clinic n=13,346, Total n=37,825). E. Impact of vaccination status and vaccine production company on the average length of hospital stays. Left: results of unvaccinated (-) or vaccinated (+) patients of different doses were shown. Right: results of different vaccine companies including SINOVAC BIOTECH, Beijing Institute of Biological products, CanSino Biologics Inc, Wuhan Institute of Biological Products, Zhifei Longcom Biopharmaceutical. Unpaired t-tests (left) and one-way ANOVA (right), (ns= not significant). (Unvaccinated n=10,984, Vaccinated n=26,841; SINOVAC BIOTECH n = 17,878, Beijing Institute of Biological products n=6,531, CanSino Biologics Inc n=601, Wuhan Institute of Biological Products n=1,405, Zhifei Longcom Biopharmaceutical n=426).